Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 498-504

  Pal, Sangita ^a   Rosas, Juan M ^a   Rosas Acosta, Germán ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

Influenza; IRES; NS1A; SUMO; SUMOylation; Ubc9

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN BETA1; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 1A; PROTEIN UBC9; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CISTRON; CONJUGATION; CONTROLLED STUDY; DICISTRONIC EXPRESSION CONSTRUCT; GENE CONSTRUCT; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN TARGETING; SUMOYLATION; VIRUS CELL INTERACTION; VIRUS EXPRESSION;

GENETIC VECTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; ORTHOMYXOVIRIDAE; PLASMIDS; SUMO-1 PROTEIN; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINATION; VIRAL NONSTRUCTURAL PROTEINS;

ORTHOMYXOVIRIDAE;

EID: 73049115776     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.11.010     Document Type: Article

References (49)

1. Billharz R., Zeng H., Proll S.C., Korth M.J., Lederer S., Albrecht R., Goodman A.G., Rosenzweig E., Tumpey T.M., Garcia-Sastre A., and Katze M.G. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J. Virol. 83 (2009) 10557-10570
2. Boggio R., and Chiocca S. Viruses and sumoylation: recent highlights. Curr. Opin. Microbiol. 9 (2006) 430-436
3. Cooper H.J., Tatham M.H., Jaffray E., Heath J.K., Lam T.T., Marshall A.G., and Hay R.T. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction. Anal. Chem. 77 (2005) 6310-6319
4. Desterro J.M., Rodriguez M.S., Kemp G.D., and Hay R.T. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274 (1999) 10618-10624
5. Desterro J.M., Thomson J., and Hay R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417 (1997) 297-300
6. Dohmen R.J. SUMO protein modification. Biochim. Biophys. Acta 1695 (2004) 113-131
7. Duprez E., Saurin A.J., Desterro J.M., Lallemand-Breitenbach V., Howe K., Boddy M.N., Solomon E., de The H., Hay R.T., and Freemont P.S. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112 (1999) 381-393
8. Eaton E.M., and Sealy L. Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278 (2003) 33416-33421
9. Gack M.U., Albrecht R.A., Urano T., Inn K.S., Huang I.C., Carnero E., Farzan M., Inoue S., Jung J.U., and Garcia-Sastre A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5 (2009) 439-449
10. Geiss-Friedlander R., and Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell. Biol. 8 (2007) 947-956
11. Gravel A., Dion V., Cloutier N., Gosselin J., and Flamand L. Characterization of human herpesvirus 6 variant B immediate-early 1 protein modifications by small ubiquitin-related modifiers. J. Gen. Virol. 85 (2004) 1319-1328
12. Hale B.G., Knebel A., Botting C.H., Galloway C.S., Precious B.L., Jackson D., Elliott R.M., and Randall R.E. CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 383 (2009) 6-11
13. Hale B.G., Randall R.E., Ortin J., and Jackson D. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89 (2008) 2359-2376
14. Herz C., Stavnezer E., Krug R., and Gurney Jr. T. Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells. Cell 26 (1981) 391-400
15. Jackson D.A., Caton A.J., McCready S.J., and Cook P.R. Influenza virus RNA is synthesized at fixed sites in the nucleus. Nature 296 (1982) 366-368
16. Jakobs A., Himstedt F., Funk M., Korn B., Gaestel M., and Niedenthal R. Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation. Nucleic Acids Res. 35 (2007) e109
17. Jakobs A., Koehnke J., Himstedt F., Funk M., Korn B., Gaestel M., and Niedenthal R. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat. Methods 4 (2007) 245-250
18. Janssen K., Hofmann T.G., Jans D.A., Hay R.T., Schulze-Osthoff K., and Fischer U. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. Oncogene 26 (2007) 1557-1566
19. Jiao P., Tian G., Li Y., Deng G., Jiang Y., Liu C., Liu W., Bu Z., Kawaoka Y., and Chen H. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J. Virol. 82 (2008) 1146-1154
20. Johnson E.S. Protein modification by sumo. Annu. Rev. Biochem. 73 (2004) 355-382
21. Krug R.M., Yuan W., Noah D.L., and Latham A.G. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309 (2003) 181-189
22. Li S., Min J.Y., Krug R.M., and Sen G.C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349 (2006) 13-21
23. Li W.X., Li H., Lu R., Li F., Dus M., Atkinson P., Brydon E.W., Johnson K.L., Garcia-Sastre A., Ball L.A., Palese P., and Ding S.W. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1350-1355
24. Lu Y., Wambach M., Katze M.G., and Krug R.M. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214 (1995) 222-228
25. Ludwig S., Wang X., Ehrhardt C., Zheng H., Donelan N., Planz O., Pleschka S., Garcia-Sastre A., Heins G., and Wolff T. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76 (2002) 11166-11171
26. Mahajan R., Gerace L., and Melchior F. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 140 (1998) 259-270
27. Mahmoudian S., Auerochs S., Grone M., and Marschall M. Influenza A virus proteins PB1 and NS1 are subject to functionally important phosphorylation by protein kinase C. J. Gen. Virol. 90 (2009) 1392-1397
28. Matic I., van Hagen M., Schimmel J., Macek B., Ogg S.C., Tatham M.H., Hay R.T., Lamond A.I., Mann M., and Vertegaal A.C. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell. Proteomics 7 (2008) 132-144
29. Matunis M.J., Wu J., and Blobel G. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol. 140 (1998) 499-509
30. Min J.Y., and Krug R.M. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7100-7105
31. Nemeroff M.E., Barabino S.M., Li Y., Keller W., and Krug R.M. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol. Cell 1 (1998) 991-1000
32. Nemeroff M.E., Qian X.Y., and Krug R.M. The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212 (1995) 422-428
33. Noah D.L., Twu K.Y., and Krug R.M. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology 307 (2003) 386-395
34. Okuma T., Honda R., Ichikawa G., Tsumagari N., and Yasuda H. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254 (1999) 693-698
35. Pedrioli P.G., Raught B., Zhang X.D., Rogers R., Aitchison J., Matunis M., and Aebersold R. Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods 3 (2006) 533-539
36. Pestova T.V., Kolupaeva V.G., Lomakin I.B., Pilipenko E.V., Shatsky I.N., Agol V.I., and Hellen C.U. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7029-7036
37. Petri T., Patterson S., and Dimmock N.J. Polymorphism of the NS1 proteins of type A influenza virus. J. Gen. Virol. 61 Pt 2 (1982) 217-231
38. Pichler A., Gast A., Seeler J.S., Dejean A., and Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108 (2002) 109-120
39. Privalsky M.L., and Penhoet E.E. The structure and synthesis of influenza virus phosphoproteins. J. Biol. Chem. 256 (1981) 5368-5376
40. Qiu Y., and Krug R.M. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68 (1994) 2425-2432
41. Rosas-Acosta G., Langereis M.A., Deyrieux A., and Wilson V.G. Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 331 (2005) 190-203
42. Rosas-Acosta G., Russell W.K., Deyrieux A., Russell D.H., and Wilson V.G. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 4 (2005) 56-72
43. Rosas-Acosta G., and Wilson V.G. Viruses and Sumoylation. In: Wilson V.G. (Ed). Sumoylation: Molecular Biology and Biochemistry (2004), Horizon Bioscience, Norfolk, UK 331-377
44. Talon J., Horvath C.M., Polley R., Basler C.F., Muster T., Palese P., and Garcia-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74 (2000) 7989-7996
45. Tatham M.H., Rodriguez M.S., Xirodimas D.P., and Hay R.T. Detection of protein SUMOylation in vivo. Nat. Protoc. 4 (2009) 1363-1371
46. Wang X., Li M., Zheng H., Muster T., Palese P., Beg A.A., and Garcia-Sastre A. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74 (2000) 11566-11573
47. Wu Y.C., Roark A.A., Bian X.L., and Wilson V.G. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology 378 (2008) 329-338
48. Yamaguchi T., Sharma P., Athanasiou M., Kumar A., Yamada S., and Kuehn M.R. Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development. Mol. Cell. Biol. 25 (2005) 5171-5182
49. Yuan W., and Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. Embo J. 20 (2001) 362-371